- Home
- PEPG vs KOSS Comparison
PEPG vs KOSS Comparison
Compare PEPG & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- KOSS
- Stock Information
- Founded
- PEPG 2018
- KOSS 1953
- Country
- PEPG United States
- KOSS United States
- Employees
- PEPG N/A
- KOSS N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- KOSS Consumer Electronics/Appliances
- Sector
- PEPG Health Care
- KOSS Consumer Staples
- Exchange
- PEPG Nasdaq
- KOSS Nasdaq
- Market Cap
- PEPG 64.2M
- KOSS 62.5M
- IPO Year
- PEPG 2022
- KOSS N/A
- Fundamental
- Price
- PEPG $1.37
- KOSS $5.99
- Analyst Decision
- PEPG Buy
- KOSS
- Analyst Count
- PEPG 3
- KOSS 0
- Target Price
- PEPG $14.67
- KOSS N/A
- AVG Volume (30 Days)
- PEPG 486.5K
- KOSS 67.7K
- Earning Date
- PEPG 03-05-2025
- KOSS 01-30-2025
- Dividend Yield
- PEPG N/A
- KOSS N/A
- EPS Growth
- PEPG N/A
- KOSS N/A
- EPS
- PEPG N/A
- KOSS N/A
- Revenue
- PEPG N/A
- KOSS $12,289,961.00
- Revenue This Year
- PEPG N/A
- KOSS N/A
- Revenue Next Year
- PEPG N/A
- KOSS N/A
- P/E Ratio
- PEPG N/A
- KOSS N/A
- Revenue Growth
- PEPG N/A
- KOSS N/A
- 52 Week Low
- PEPG $1.16
- KOSS $2.27
- 52 Week High
- PEPG $19.30
- KOSS $18.73
- Technical
- Relative Strength Index (RSI)
- PEPG 31.82
- KOSS 39.58
- Support Level
- PEPG $1.16
- KOSS $5.86
- Resistance Level
- PEPG $1.60
- KOSS $6.65
- Average True Range (ATR)
- PEPG 0.14
- KOSS 0.41
- MACD
- PEPG 0.11
- KOSS 0.01
- Stochastic Oscillator
- PEPG 48.28
- KOSS 21.43
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.